Trial Outcomes & Findings for Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses (NCT NCT00663819)

NCT ID: NCT00663819

Last Updated: 2018-04-17

Results Overview

The primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 4 - 12 weeks post procedure.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

258 participants

Primary outcome timeframe

Completion of procedure through 4-12 weeks post procedure

Results posted on

2018-04-17

Participant Flow

Participant milestones

Participant milestones
Measure
Device
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Overall Study
STARTED
123
135
Overall Study
COMPLETED
123
135
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Total
n=258 Participants
Total of all reporting groups
Age, Continuous
54.7 years
n=5 Participants
56.1 years
n=7 Participants
55.4 years
n=5 Participants
Sex: Female, Male
Female
63 Participants
n=5 Participants
42 Participants
n=7 Participants
105 Participants
n=5 Participants
Sex: Female, Male
Male
60 Participants
n=5 Participants
93 Participants
n=7 Participants
153 Participants
n=5 Participants
Region of Enrollment
United States
123 participants
n=5 Participants
135 participants
n=7 Participants
258 participants
n=5 Participants

PRIMARY outcome

Timeframe: Completion of procedure through 4-12 weeks post procedure

The primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 4 - 12 weeks post procedure.

Outcome measures

Outcome measures
Measure
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Proportion of Subjects Who Experience a Clinical and/or Radiologic Anastomotic Leak
14 Participants
17 Participants

SECONDARY outcome

Timeframe: Post operative

Outcome measures

Outcome measures
Measure
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Identify and Compare the Rate of Anastomotic Stenosis Associated With Circular Stapled Anastomoses Constructed With and Without CBSG.
1 Participants
11 Participants

SECONDARY outcome

Timeframe: Post operative

Outcome measures

Outcome measures
Measure
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Determine the Rate of Significant Staple Line Hemorrhage With and Without the Use of CBSG in Circular Stapled Anastomoses
2 Participants
6 Participants

SECONDARY outcome

Timeframe: Within 4 - 12 weeks post-surgery

Population: "Significant" Post Operative Complications

Compare th number of patients experiencing significant post-operative complications when performing high-risk colorectal, coloanal, and Ileoanal anastomoses across both groups studied.

Outcome measures

Outcome measures
Measure
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Determine the Efficacy and Further Substantiate Safety of CBSG Used in Conjunction With Circular Staplers When Performing High-risk Colorectal, Coloanal, and Ileoanal Anastomoses.
13 Participants
10 Participants

Adverse Events

GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement

Serious events: 21 serious events
Other events: 16 other events
Deaths: 0 deaths

Procedure/Surgery

Serious events: 28 serious events
Other events: 49 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 participants at risk
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 participants at risk
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Surgical and medical procedures
Anastomotic Leak, significant
10.6%
13/123 • Number of events 123 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
7.4%
10/135 • Number of events 135 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Infections and infestations
Deep organ space infection
2.4%
3/123 • Number of events 3 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
3.7%
5/135 • Number of events 5 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Infections and infestations
Peritonitis
1.6%
2/123 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
0.74%
1/135 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Gastrointestinal disorders
Bowel obstruction
2.4%
3/123 • Number of events 3 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
8.9%
12/135 • Number of events 12 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Gastrointestinal disorders
Prolonged ileus
14.6%
18/123 • Number of events 18 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
16.3%
22/135 • Number of events 22 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery

Other adverse events

Other adverse events
Measure
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 participants at risk
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
Procedure/Surgery
n=135 participants at risk
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
Surgical and medical procedures
Anastomotic leak, non-significant
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
5.2%
7/135 • Number of events 7 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Infections and infestations
Superficial wound infection
8.9%
11/123 • Number of events 11 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
17.0%
23/135 • Number of events 23 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Surgical and medical procedures
Anastomotic bleeding
1.6%
2/123 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
4.4%
6/135 • Number of events 6 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
General disorders
Fistula formation
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
1.5%
2/135 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
Surgical and medical procedures
Stenosis (stricture)
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
8.1%
11/135 • Number of events 11 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery

Additional Information

Dr. Anthony Senagore

CMU College of Medicine

Phone: 989-790-1001

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60